How To Choose Fluorescent Dyes?
Fluorescence refers to the phenomenon of photoluminescence. When a certain room temperature substance is irradiated by incident light of a certain wavelength, after absorbing the
Fluorescence refers to the phenomenon of photoluminescence. When a certain room temperature substance is irradiated by incident light of a certain wavelength, after absorbing the
With the rapid growth of bioinformatics knowledge related to peptides and proteins, peptide-based drug design strategies have become increasingly active recently. In the past, peptide-based
DNA is colorless, so if we want to see it, we need to use staining techniques. Since the maturity of PCR technology, DNA staining methods
Since the launch of the first CAR-T cell therapy in 2017, the era of cell therapy has officially begun, and good clinical results have been
To talk about the disadvantages of random coupling, there are two main points. First, random coupling mainly relies on natural amino acids, and the coupling
The toxicity of ADC drugs mainly comes from two aspects, namely the toxicity produced by antibody molecules and the toxicity produced by toxin molecules. The
The basic principle of fluorescence microscopy is the highly specific visualization of cellular components with the aid of fluorescent dyes. This may be a fluorescent
A rationale for fluorescent dyes is the highly specific visualization of cellular components with the help of fluorescent agents. It can be a fluorescent protein,
Immune cells in a broad sense refer to all cells involved in or related to immune responses, mainly all leukocytes and non-leukocyte antigen-presenting cells (such
Fluorescein is divided into four categories according to the excitation wavelength, which are mainly 375nm, 405nm, 488nm and 633nm. Among them, fluoresceins with excitation wavelengths
Monoclonal antibody drugs, the full name is also known as monoclonal antibody drugs. As the name suggests, these drugs are closely related to the body’s
1. Trodelvy Trodelvy (sacituzumab govitecan-hziy) is the first approved antibody-conjugated drug targeting Trop-2 (human trophoblast cell surface antigen 2), and has been granted breakthrough therapy